Beam Therapeutics Inc. Annual Income Tax Expense (Benefit) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Beam Therapeutics Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
  • Beam Therapeutics Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $39K.
  • Beam Therapeutics Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $1.41M, a 58.8% decline year-over-year.
  • Beam Therapeutics Inc. annual Income Tax Expense (Benefit) for 2023 was $1.37M, a 59.9% decline from 2022.
  • Beam Therapeutics Inc. annual Income Tax Expense (Benefit) for 2022 was $3.41M.
  • Beam Therapeutics Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.